Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 20 Uterine Hemorrhage 2 Infertility, Female 2 Infertility 2 Breast Neoplasms 2 Uterine Neoplasms 1 Pregnancy Complications 1 Menorrhagia 1

Interventions

estradiol, norethindrone drug combination 9 elagolix 7 Estradiol 7 asoprisnil 6 Uterine Artery Embolization 6 relugolix 5 Norethindrone Acetate 5 vilaprisan 4 Uterine Myomectomy 4 linzagolix 2 Tranexamic Acid 2 ziprasidone 1 ulipristal acetate 1 ulipristal 1 pycnogenols 1 Zolpidem 1 Warfarin 1 Vecuronium Bromide 1 Vancomycin 1 Tobramycin 1 Spironolactone 1 Sevelamer 1 Rocuronium 1 Radiofrequency Ablation 1 Progesterone 1 Piperacillin, Tazobactam Drug Combination 1 Pentobarbital 1 Oxycodone 1 Nifedipine 1 Nafcillin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Menorrhagia × ulipristal acetate × Clear all

NCT04132349 2020-04-13

Ulipristal Acetate in Symptomatic Uterine Fibroid

Mỹ Đức Hospital

Phase 4 Terminated

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡